Shares of Humana Inc. HUM shed 1.82% to $264.58 Friday, on what proved to be an all-around poor trading session for the stock ...

Humana’s (HUM) ongoing litigation with the Center for Medicaid & Medicaid Services on its Medicare Advantage Stars performance remains a ...

A month has gone by since the last earnings report for Humana (HUM). Shares have lost about 4.2% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading up ...

The company's recent financial performance has been mixed. While Humana has maintained a solid market position with a healthy free cash flow yield of 8% and 14 consecutive years of dividend ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at where Humana Inc. (NYSE:HUM) stands against the other health insurance stocks.

Humana (HUM) stock is plunging in Wednesday's session after the health benefits company announced preliminary 2025 Medicare Advantage (MA) Star Ratings data provided by the Centers for Medicare ...

Humana (NYSE:HUM – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Tuesday. HUM has been the topic of ...

Shares of Humana Inc. HUM slid 3.28% to $251.25 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 and Dow ...